
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). Cyxones technologies have the potential to address an unmet need to develop new effective and safe medicines that can improve the quality of life for patients affected by autoimmune diseases. The companys development portfolio comprises rabeximod in a clinical phase II program for RA and T20K that has successfully completed phase I infusion study for MS
Biotechnology,multiple sclerosis,rheumatoid arthritis,clinical stage,cyclotides,immunomodulating drugs,oral drugs,and autoimmune diseases
Cyxone operates in the Biotechnology research industry.
Cyxone's revenue is 11m - 100m
Cyxone has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.